Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials (Q41452053)
Jump to navigation
Jump to search
scientific article published on 23 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials |
scientific article published on 23 February 2015 |
Statements
1 reference
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials (English)
1 reference
Mario Castro
James Zangrilli
Michael E Wechsler
Eric D Bateman
Philip Bardin
Kevin Murphy
Jorge F Maspero
Christopher O'Brien
23 February 2015
1 reference